Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Melanoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 494 Leukemia 250 Precursor Cell Lymphoblastic Leukemia-Lymphoma 196 Lymphoma 135 Myelodysplastic Syndromes 94 Leukemia, Monocytic, Acute 77 Burkitt Lymphoma 76 Congenital Abnormalities 75 Lymphoma, Non-Hodgkin 74 Leukemia, Myelomonocytic, Acute 74 Leukemia, Erythroblastic, Acute 69 Leukemia, Megakaryoblastic, Acute 66 Lymphoma, Large B-Cell, Diffuse 65 Recurrence 58 Lymphoma, Mantle-Cell 58 Lymphoma, Follicular 41 Hodgkin Disease 40 Leukemia, Myelomonocytic, Chronic 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 33 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Blast Crisis 28 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 23 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Eosinophilic, Acute 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Basophilic, Acute 20

Interventions

pembrolizumab 246 Nivolumab 222 Ipilimumab 201 Cyclophosphamide 119 aldesleukin 117 Interleukin-2 89 trametinib 65 Dacarbazine 63 fludarabine 61 Vemurafenib 60 Temozolomide 59 dabrafenib 58 fludarabine phosphate 54 Radiosurgery 43 sargramostim 39 Bevacizumab 39 Biopsy 38 incomplete Freund's adjuvant 35 Paclitaxel 34 binimetinib 33 Cisplatin 32 Radiotherapy 31 Magnetic Resonance Spectroscopy 30 atezolizumab 29 Carboplatin 29 cobimetinib 28 encorafenib 27 Specimen Handling 27 Introns 27 CTLA-4 Antigen 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡